You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

oHCM

Showing 1 - 16 of 16
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Effect of Mavacamten Treatment on Coronary Flow Reserve in oHCM

Not yet recruiting
  • Obstructive Hypertrophic Cardiomyopathy
  • Charlottesville, Virginia
    University of Virginia
Aug 28, 2023

Mavacamten in Korean Symptomatic Obstructive Hypertrophic

Not yet recruiting
  • Obstructive Hypertrophic Cardiomyopathy
  • Seoul, Korea, Republic of
    Bristol-Myers Squibb YH
Nov 23, 2023

Obstructive Hypertrophic Cardiomyopathy Trial in China (Aficamten)

Not yet recruiting
  • Obstructive Hypertrophic Cardiomyopathy
  • Beijing, China
  • +9 more
Oct 31, 2023

Obstructive Hypertrophic Cardiomyopathy (oHCM) Trial (Aficamten (CK-3773274) (5 mg, 10 mg, 15 mg and 20 mg), Placebo to match

Not yet recruiting
  • Obstructive Hypertrophic Cardiomyopathy (oHCM)
  • Aficamten (CK-3773274) (5 mg, 10 mg, 15 mg and 20 mg)
  • +3 more
  • (no location specified)
Mar 2, 2023

Obstructive Hypertrophic Cardiomyopathy (oHCM) Trial in Worldwide (CK-3773274 (5 mg, 10 mg, 15 mg and 20 mg), Placebo to match

Recruiting
  • Obstructive Hypertrophic Cardiomyopathy (oHCM)
  • CK-3773274 (5 mg, 10 mg, 15 mg and 20 mg)
  • Placebo to match CK-3773274
  • Anchorage, Alaska
  • +31 more
Aug 9, 2022

Obstructive Hypertrophic Cardiomyopathy Trial in Milan (pace maker implant guided by acute hemodynamic testing)

Recruiting
  • Obstructive Hypertrophic Cardiomyopathy
  • pace maker implant guided by acute hemodynamic testing
  • Milan, Italy
    Istituto Auxologico Italiano
Mar 6, 2023

Obstructive Hypertrophic Cardiomyopathy Trial in Boston, Kansas City, Omaha

Not yet recruiting
  • Obstructive Hypertrophic Cardiomyopathy
    • (no location specified)
    Aug 3, 2022

    Obstructive Hypertrophic Cardiomyopathy Trial in Beijing (Mavacamten, Placebo)

    Recruiting
    • Obstructive Hypertrophic Cardiomyopathy
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Jan 17, 2022

    Symptomatic Hypertrophic Cardiomyopathy (HCM) Trial in Italy, Spain, United States (CK-3773274 (5 - 20 mg))

    Enrolling by invitation
    • Symptomatic Hypertrophic Cardiomyopathy (HCM)
    • CK-3773274 (5 - 20 mg)
    • Los Angeles, California
    • +18 more
    Jan 31, 2023

    Hypertrophic Cardiomyopathy (HCM) Trial in Worldwide (CK-3773274 (5 - 15 mg), CK-3773274 (10 - 30 mg), Placebo for CK-3773274)

    Recruiting
    • Hypertrophic Cardiomyopathy (HCM)
    • CK-3773274 (5 - 15 mg)
    • +2 more
    • Los Angeles, California
    • +21 more
    Mar 4, 2022

    Cardiomyopathy, Hypertrophic Trial in Worldwide (Mavacamten, Placebo)

    Not yet recruiting
    • Cardiomyopathy, Hypertrophic
    • West Hollywood, California
    • +9 more
    Oct 27, 2023

    Obstructive Hypertrophic Cardiomyopathy, Healthy Adult Subjects Trial in Beijing (CK-3773274, Placebo)

    Completed
    • Obstructive Hypertrophic Cardiomyopathy
    • Healthy Adult Subjects
    • Beijing, Beijing, China
      Clinical Site
    Sep 12, 2021

    Cardiomyopathy, Hypertrophic Trial in Bologna, Alicante/alacant (MYK-224)

    Not yet recruiting
    • Cardiomyopathy, Hypertrophic
    • Bologna, BO, Italy
    • +1 more
    Sep 23, 2022

    Hypertrophic Cardiomyopathy Trial in United States (mavacamten)

    Active, not recruiting
    • Hypertrophic Cardiomyopathy
    • Scottsdale, Arizona
    • +3 more
    Jun 10, 2022

    Obstructive Hypertrophic Cardiomyopathy Trial in Worldwide (mavacamten, Placebo)

    Completed
    Has Results
    • Obstructive Hypertrophic Cardiomyopathy
    • Scottsdale, Arizona
    • +70 more
    Sep 7, 2021

    Symptomatic Obstructive Hypertrophic Cardiomyopathy, Healthy Subjects Trial in Tempe (CK-3773274 - Granules in Capsule, Placebo

    Completed
    • Symptomatic Obstructive Hypertrophic Cardiomyopathy
    • Healthy Subjects
    • CK-3773274 - Granules in Capsule
    • +2 more
    • Tempe, Arizona
      Clinical Site
    Jan 28, 2020